Kiora Pharmaceuticals (KPRX) Assets Average (2015 - 2026)

Kiora Pharmaceuticals (KPRX) has reported Assets Average for 12 consecutive years, with $22.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets Average fell 31.78% year-over-year to $22.5 million; the trailing twelve-month figure through Jun 2026 stood at $22.5 million (down 31.78% YoY), and the FY2025 full-year result was $30.4 million, up 21.0% from the prior year.
• Assets Average eased to $22.5 million in Q2 2026 per KPRX's latest filing, from $22.7 million in the prior quarter.
• Across five years, Assets Average topped out at $41.6 million in Q2 2024 and bottomed at $14.8 million in Q4 2023.
• Historically, Assets Average has averaged $25.4 million across 5 years, with a median of $22.6 million in 2026.
• The sharpest annual moves came in 2024 and 2026: Assets Average soared 153.29% in 2024, then plunged 35.49% in 2026.
• Over 5 years, Assets Average stood at $18.2 million in 2022, then retreated by 18.53% to $14.8 million in 2023, then jumped by 153.29% to $37.5 million in 2024, then slipped by 27.84% to $27.1 million in 2025, then decreased by 16.84% to $22.5 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $22.5 million, $22.7 million, and $27.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.